Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan ; volume:21 ; number:1 ; day:16 ; month:4 ; year:2019 ; pages:1-3 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (16.4.2019), 1-3, 12.2019
- Creator
-
Tanaka, Yoshiya
Wada, Kazuteru
Takahashi, Yoshinori
Hagino, Owen
Hoogstraten, Hubert van
Graham, Neil M. H.
Kameda, Hideto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-019-1887-x
- URN
-
urn:nbn:de:101:1-2019051022443235552786
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
04.04.2002, 8:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tanaka, Yoshiya
- Wada, Kazuteru
- Takahashi, Yoshinori
- Hagino, Owen
- Hoogstraten, Hubert van
- Graham, Neil M. H.
- Kameda, Hideto
- SpringerLink (Online service)
Other Objects (12)
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
Correction: Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
Rheumatoid arthritis
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Genome-oriented treatment strategies for autoimmune diseases
ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients
Methotrexate
Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
Correction: Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
Rheumatoid arthritis
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Genome-oriented treatment strategies for autoimmune diseases
ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients
Methotrexate
Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
Correction: Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
Rheumatoid arthritis
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Genome-oriented treatment strategies for autoimmune diseases
ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients
Methotrexate
Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial